EIF4EBP1 and hepatocellular carcinoma: The result shows that 53% (47/88) of HCCs exhibit high expression of EIF4EBP1 compared with the matched NCLs (Fig. 1C, and S1 Table in Supporting Information) and that EIF4EBP1 expression level in HCC is significantly higher than that in NCL (Fig. 1D), which is similar to the percentage of high EIF4EBP1 mRNA expression in 40 HCCs, confirming EIF4EBP1 overexpression in HCC.